The Week AI Drug Discovery Outpaced Its Own Skeptics
Rentosertib's Phase IIa results transformed a year of biotech press releases into something harder to dismiss — a drug designed by AI that works in patients.
Rentosertib's Phase IIa results transformed a year of biotech press releases into something harder to dismiss — a drug designed by AI that works in patients.
You've read 10 of 10 free stories this month. Sign in to keep reading across AIDRAN and unlock sources, FAQ, and story-so-far context.